"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 3 | 4 |
| 1997 | 3 | 2 | 5 |
| 1998 | 2 | 1 | 3 |
| 1999 | 3 | 1 | 4 |
| 2000 | 9 | 3 | 12 |
| 2001 | 4 | 0 | 4 |
| 2002 | 3 | 6 | 9 |
| 2003 | 2 | 4 | 6 |
| 2004 | 3 | 3 | 6 |
| 2005 | 5 | 9 | 14 |
| 2006 | 3 | 6 | 9 |
| 2007 | 3 | 3 | 6 |
| 2008 | 3 | 4 | 7 |
| 2009 | 5 | 6 | 11 |
| 2010 | 2 | 4 | 6 |
| 2011 | 5 | 3 | 8 |
| 2012 | 7 | 8 | 15 |
| 2013 | 6 | 8 | 14 |
| 2014 | 7 | 9 | 16 |
| 2015 | 8 | 12 | 20 |
| 2016 | 7 | 5 | 12 |
| 2017 | 4 | 8 | 12 |
| 2018 | 6 | 6 | 12 |
| 2019 | 5 | 10 | 15 |
| 2020 | 4 | 2 | 6 |
| 2021 | 12 | 3 | 15 |
| 2022 | 18 | 0 | 18 |
| 2023 | 3 | 0 | 3 |
| 2024 | 3 | 3 | 6 |
| 2025 | 3 | 5 | 8 |
| 2026 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess. Cell Metab. 2026 Aug 04; 38(8):1540-1556.
-
Long-Term Effects of Maternal Glycemic Measures in Pregnancy and Offspring Adverse Glycemic Outcomes: Results from the TEAM Study. Am J Perinatol. 2026 06; 43(8):1082-1090.
-
ChREBP drives ß-cell proliferation under metabolic stress but not in pregnancy-induced ß-cell expansion. J Diabetes Investig. 2026 Jun; 17(6):938-950.
-
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysis. Med. 2026 May 08; 7(5):101077.
-
On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2025 12 18; 111(1):11-23.
-
Platelets impair the resolution of inflammation in atherosclerotic plaques in insulin-resistant mice after lipid lowering. JCI Insight. 2025 11 10; 10(21).
-
Influence of Weight Loss and Weight Regain on Adipose Tissue Inflammation. Arterioscler Thromb Vasc Biol. 2025 12; 45(12):2155-2163.
-
Metabolic Effects of Gender-Affirming Hormonal Therapy in Youth. Pediatr Ann. 2025 Oct; 54(10):e355-e360.
-
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic ß-cell function in obese male mice. Nat Commun. 2025 May 21; 16(1):4714.
-
Semaglutide and bariatric surgery induce distinct changes in the composition of mouse white adipose tissue. Mol Metab. 2025 May; 95:102126.